Page 175 - EJMO-9-2

Eurasian Journal of
Medicine and Oncology Genetic insights into CAD drug targets

doi: 10.1161/CIRCGEN.119.002876 doi: 10.1038/s41577-022-00792-3
30. Li R, Zhang H, Tang F, et al. Coronary artery disease risk 36. Armstrong AW, Read C. Pathophysiology, clinical
factors affected by RNA modification-related genetic presentation, and treatment of psoriasis: A review. JAMA.
variants. Front Cardiovasc Med. 2022;9:985121. 2020;323(19):1945-1960.
doi: 10.3389/fcvm.2022.985121 doi: 10.1001/jama.2020.4006
31. Wallach D. The cybernetics of TNF: Old views and newer 37. Wride AM, Chen GF, Spaulding SL, Tkachenko E, Cohen JM.
ones. Semin Cell Dev Biol. 2016;50:105-114. Biologics for psoriasis. Dermatol Clin. 2024;42(3):339-355.
doi: 10.1016/j.semcdb.2015.10.014 doi: 10.1016/j.det.2024.02.001
32. Andersson J, Sundstrom J, Kurland L, et al. The carotid 38. Efferth T, Oesch F. The immunosuppressive activity
artery plaque size and echogenicity are related to different of artemisinin-type drugs towards inflammatory and
cardiovascular risk factors in the elderly: The prospective autoimmune diseases. Med Res Rev. 2021;41(6):3023-3061.
investigation of the vasculature in Uppsala seniors (PIVUS)
study. Lipids. 2009;44(5):397-403. doi: 10.1002/med.21842
doi: 10.1007/s11745-009-3281-y 39. Shi Z, Chen Y, Lu C, et al. Resolving neuroinflammation,
the therapeutic potential of the anti-malaria drug family of
33. Zhang H, Jiang M, Hou H, Li Q. Efficacy of simvastatin artemisinin. Pharmacol Res. 2018;136:172-180.
on carotid atherosclerotic plaque and its effects on serum
inflammatory factors and cardiocerebrovascular events in doi: 10.1016/j.phrs.2018.09.002
elderly patients. Exp Ther Med. 2021;22(2):819. 40. Huang Y, Chen L, Li L, et al. Downregulation of
doi: 10.3892/etm.2021.10251 adipose LPL by PAR2 contributes to the development of
hypertriglyceridemia. JCI Insight. 2024;9(13):e173240.
34. Mourouzis K, Oikonomou E, Siasos G, et al. Pro-
inflammatory cytokines in acute coronary syndromes. Curr doi: 10.1172/jci.insight.173240
Pharm Des. 2020;26(36):4624-4647. 41. Xie L, Li YM. Lipoprotein lipase (LPL) polymorphism and
doi: 10.2174/1381612826666200413082353 the risk of coronary artery disease: A meta-analysis. Int J
Environ Res Public Health. 2017;14(1):84.
35. van Loo G, Bertrand MJM. Death by TNF: A road to
inflammation. Nat Rev Immunol. 2023;23(5):289-303. doi: 10.3390/ijerph14010084

Volume 9 Issue 2 (2025) 167 doi: 10.36922/ejmo.7387